| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.0075 | 0.9 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |